Last update :
08/05/2024
Anti-inflammatory   Ketoprofene  
Injection
Ointments Oral solution Suppository
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Artrosilene Italy
Bibix Mexico
Bioketof Venezuela
Deflogix Portugal
Dolaret Peru
Dolofast Ecuador
Dolomax Colombia, Venezuela
Flexen Italy, Morocco, Tunisia
Flogofin Chile
Ibifen Italy
Ketonal Poland, Slovenia
Ketoprofene France
Ketoprofeno Chile, Ecuador
Ketorin Finland
Orudis Italy
Profenid Austria, Brazil, Chile, Colombia, Denmark, Egypt, France, Germany, Great Britain, Hungary, Ireland, Italy, Japan, Luxembourg, Mexico, Morocco, Netherlands, Peru, Poland, Portugal, Sweden, Turkey
Vetofen Iran
References   Injection   References : Ketoprofene  
Type Publication
1646 Journal Kannan S.
Incompatibility of prochlorperazine and ketoprofen.
Anaesthesia 2001 ; 56: 920.
1847 Journal Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.
Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration.
J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241.
1859 Journal Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Il Farmaco 2002 ; 57: 925-930.
2122 Journal Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.
Stability and compatibility of paracetamol injection admixed with ketoprofen.
EJHP Science 2006 ; 12, 4: 81-84.
3075 Journal Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
EJHP Science 2009 ; 15, 4: 78-82.

  Mentions Légales